Diagnosis and management of monoclonal gammopathy of clinical significance
Blood Research
;
: S20-S26, 2022.
Article
in English
| WPRIM
| ID: wpr-925634
ABSTRACT
The term “monoclonal gammopathy of clinical significance” (MGCS) refers to any plasma cell or B-cell clonal disorder that does not meet the current criteria for malignant disorders but produces a monoclonal protein that directly or indirectly results in organ damage. The most commonly affected organs are the kidneys, nerves, and skin. This review summarizes the current classification of MGCS and its diagnostic and treatment approaches.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Diagnostic study
Language:
English
Journal:
Blood Research
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS